Detalles de la búsqueda
1.
Increasing accrual of minority patients in breast cancer clinical trials.
Breast Cancer Res Treat
; 184(2): 499-505, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32840699
2.
Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
Breast Cancer Res Treat
; 175(1): 247-259, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30725384
3.
The impact of communication style on patient satisfaction.
Breast Cancer Res Treat
; 176(2): 349-356, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31025271
4.
Associations of preoperative breast magnetic resonance imaging with subsequent mastectomy and breast cancer mortality.
Breast Cancer Res Treat
; 172(2): 453-461, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30099634
5.
Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I-III HER2-positive breast cancer.
Breast Cancer Res Treat
; 169(2): 333-340, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29396664
6.
Mucosal haemangioma in the setting of treatment with trastuzumab emtansine (T-DM1).
Br J Dermatol
; 187(5): e168, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35633104
7.
New Therapeutic Strategies for Triple-Negative Breast Cancer.
Oncology (Williston Park)
; 31(2): 130-7, 2017 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28205193
8.
Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ.
Breast Cancer Res Treat
; 158(1): 139-148, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27287780
9.
Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 14(11): 1430-1468, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27799513
10.
Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer.
Breast Cancer Res Treat
; 154(3): 533-41, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26578401
11.
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer.
J Clin Oncol
; : JCO2302344, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38833643
12.
Dermatologic toxicities of chemotherapy: an educational intervention for skin of color women with breast cancer.
Int J Womens Dermatol
; 9(1): e073, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36733315
13.
Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US.
JAMA Netw Open
; 6(7): e2323115, 2023 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37436746
14.
Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study.
J Clin Oncol
; 41(34): 5285-5295, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37656930
15.
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC).
Clin Breast Cancer
; 22(3): 269-278, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34824002
16.
Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC.
Clin Cancer Res
; 28(17): 3720-3728, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35903931
17.
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer.
Clin Cancer Res
; 28(12): 2587-2597, 2022 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35377948
18.
Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: The Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: Study protocol for a randomized clinical trial.
Contemp Clin Trials
; 109: 106508, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34274495
19.
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.
NPJ Breast Cancer
; 7(1): 9, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33558513
20.
Comprehensive cancer control--impacting every physician.
Conn Med
; 76(6): 325-6, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22856016